-
1.
公开(公告)号:MA42743A1
公开(公告)日:2019-07-31
申请号:MA42743
申请日:2016-12-14
Applicant: UCB BIOPHARMA SPRL
Inventor: SHAW STEVAN GRAHAM , MARSHALL DIANE , HEYWOOD SAM PHILIP , ADAMS RALPH , BHATTA PALLAVI , DAVE EMMA , HUMPHREYS DAVID PAUL , LIGHTWOOD DANIEL
Abstract: L'invention concerne des molécules d'anticorps multispécifiques pour tnf alpha, il-17a et il-17f, des utilisations thérapeutiques de ces molécules d'anticorps et des procédés pour la production desdites molécules d'anticorps.
-
公开(公告)号:TN2018000200A1
公开(公告)日:2019-10-04
申请号:TN2018000200
申请日:2016-12-14
Applicant: UCB BIOPHARMA SPRL
Inventor: ADAMS RALPH , BHATTA PALLAVI , DAVE EMMA , HEYWOOD SAM PHILIP , HUMPHREYS DAVID PAUL , LIGHTWOOD DANIEL , MARSHALL DIANE , SHAW STEVAN GRAHAM
Abstract: The invention relates to multi-specific antibody molecules having specificity for TNF alpha, IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
公开(公告)号:SG11201804803WA
公开(公告)日:2018-07-30
申请号:SG11201804803W
申请日:2016-12-14
Applicant: UCB BIOPHARMA SPRL
Inventor: ADAMS RALPH , BHATTA PALLAVI , DAVE EMMA , HEYWOOD SAM PHILIP , HUMPHREYS DAVID PAUL , MARSHALL DIANE , SHAW STEVAN GRAHAM , LIGHTWOOD DANIEL
Abstract: The invention relates to multi-specific antibody molecules having specificity for TNF alpha, IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
公开(公告)号:ES2615978T3
公开(公告)日:2017-06-09
申请号:ES10714046
申请日:2010-03-10
Applicant: UCB BIOPHARMA SPRL
Inventor: GOZZARD NEIL , LAWSON ALASTAIR , LIGHTWOOD DANIEL , PALFRAMAN ROGER , SMITH BRYAN , TYSON KERRY
IPC: C07K16/24 , A61K39/395 , A61P11/06 , C07K16/46 , C12N15/13
Abstract: Un anticuerpo antagonista que se une a IL-13 humana que comprende una cadena pesada, en donde el dominio variable de la cadena pesada comprende la secuencia dada en la SEQ ID NO:31 y, adicionalmente, que comprende una cadena ligera, en donde el dominio variable de la cadena ligera comprende la secuencia dada en la SEQ ID NO:23.
-
-
-